About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Malt1tm1c(EUCOMM)Hmgu
targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH
MGI:5812177
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT5-cre)5132Jlj/0 		involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * DBA/2J MGI:6460070
cn2
 		Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT14-cre/ERT)20Efu/0 		involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1 MGI:6460074


Genotype
MGI:6460070
cn1
Allelic
Composition		 Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT5-cre)5132Jlj/0
Genetic
Background		 involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation (0 available); any Gt(ROSA)26Sor mutation (1046 available)
Malt1tm1c(EUCOMM)Hmgu mutation (0 available); any Malt1 mutation (33 available)
Tg(KRT5-cre)5132Jlj mutation (1 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
mortality/aging ( J:292094 )
N
• mice exhibit normal postnatal survival




Genotype
MGI:6460074
cn2
Allelic
Composition		 Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT14-cre/ERT)20Efu/0
Genetic
Background		 involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation (0 available); any Gt(ROSA)26Sor mutation (1046 available)
Malt1tm1c(EUCOMM)Hmgu mutation (0 available); any Malt1 mutation (33 available)
Tg(KRT14-cre/ERT)20Efu mutation (3 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
integument
skin inflammation ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
thick epidermis ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
psoriasis ( J:292094 )
• from 6 weeks on, mice exhibit mild ear thickening unlike control mice
• tamoxifen-treated mice exhibit increased ear swelling that is not as severe as in mice with wild-type Matl1

immune system
increased neutrophil cell number ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
increased dendritic cell number ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
skin inflammation ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1

growth/size/body
decreased body weight ( J:292094 )
• in tamoxifen-treated that is not as severe as in mice with wild-type Matl1

hematopoietic system
increased neutrophil cell number ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
increased dendritic cell number ( J:292094 )
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
09/30/2025
MGI 6.24 		The Jackson Laboratory